← Open Payments lookup

ASHVIN PATEL: Open Payments

NPI 1730209172 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,037 in 142 payments from 14 companies in 2025. Trend: 2023 $13,738 · 2024 $7,535 · 2025 $3,037

Food & beverage: $3,037
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$536
Vanda Pharmaceuticals Inc.16$532
Alkermes, Inc.13$329
Neurocrine BioSciences, Inc.12$297
E.R. Squibb & Sons, L.L.C.10$239
Collegium Pharmaceutical, Inc.15$200
Janssen Pharmaceuticals, Inc7$197
ABBVIE INC.14$194
Takeda Pharmaceuticals U.S.A., Inc.9$150
Lundbeck LLC8$145

Products named: CAPLYTA, FANAPT, ARISTADA, INGREZZA, COBENFY, Jornay PM, VRAYLAR, SPRAVATO.

Industry payments across VA — which companies pay providers there.